Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presenter: James B. Hermiller Jr, Hiroki Shiomi

September 25, 2018

Presentation TCT Abstracts Posters 2018

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Presenter: Woo-Young Chung

September 25, 2018

Presentation TCT 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin

September 21, 2018

Presentation TCT 2018

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert

September 21, 2018

Presentation TCT 2018

TCT-197: Early Vascular Healing After Implantation of a Biolimus-Coated BioFreedom Stent or a Sirolimus Eluting Orsiro Stent in Patients with ST-segment Elevation Myocardial Infarction

Presenter: Alexandre Abizaid, Didier Carrié, Kirstine Hansen

September 21, 2018

Presentation TCT 2018

TCT-64: Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Ricardo A. Costa

September 21, 2018

Presentation TCT 2018

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

Presenter: George L Adams, Tony Das, Gireesh Warwadekar

September 21, 2018

Presentation JIM 2018

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Presenter: Luca Testa

February 22, 2018

Advertisement

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

TCT-197: Early Vascular Healing After Implantation of a Biolimus-Coated BioFreedom Stent or a Sirolimus Eluting Orsiro Stent in Patients with ST-segment Elevation Myocardial Infarction

TCT-64: Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content